Keros Therapeutics, Inc. · NASDAQ:KROS
Seth Alpna sold 2,625 Keros Therapeutics, Inc. shares (Form 4)
Traded Jun 4, 2026 · Filed Jun 5, 2026
On Jun 4, 2026, Seth Alpna (Director) sold 2,625 Keros Therapeutics, Inc. shares at US$10.72 for US$28,140 under a trading plan, leaving 9,767 shares. Filed Jun 5, 2026 (Form 4).
- Sold
- 2,625 shares
- Price
- US$10.72
- Value
- US$28,140
- Holding after
- 9,767 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | Sale | 2,625 | US$10.72 | 9,767 | Direct |
Source
Related
- Keros Therapeutics, Inc.
- Seth Alpna
- Keros Therapeutics, Inc. shareholders
- Form 4 · Seth Alpna · Jun 5, 2026
- Form 4 · Tanini Annita · Aug 20, 2026
- Form 4 · Lerner Lorena Raquel · Aug 20, 2026
- Form 4 · Cho Esther · Aug 20, 2026
- Form 4 · Newton Charles W. · Aug 20, 2026
- Form 4 · Bienaime Jean Jacques · Aug 19, 2026